12分

Diagnosis and Treatment of Systemic Lupus Erythematosus JAMA Clinical Reviews

    • 医学

Systemic lupus erythematosus (SLE) can present at any age and is associated with immune-mediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this and more with JAMA Deputy Editor Mary McGrae McDermott, MD.

Related Content:
Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) can present at any age and is associated with immune-mediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this and more with JAMA Deputy Editor Mary McGrae McDermott, MD.

Related Content:
Systemic Lupus Erythematosus

12分

JAMA Networkのその他の作品

JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
JAMA Neurology Author Interviews
JAMA Network
JAMA Psychiatry Author Interviews
JAMA Network
JAMA Ophthalmology Author Interviews
JAMA Network